Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system
Open accessAbstract
Lactic acidosis is a serious, metabolic complication that may occur due to metformin hydrochloride (MH) accumulation during the treatment of diabetes mellitus. The aim of this study is to enhance the bioavailability of MH by oral route. Span 40 and cholesterol were used for the preparation of MH-loaded niosomes by the reverse phase evaporation technique. Dicetyl phosphate (DCP) and 1,2-dioleoyl-3-trimethylammonium-propane chloride salt (DOTAP) were used to obtain negatively and positively charged vesicles, respectively. The mean particle size ranged from 223.5 to 384.6 nm and the MH-loaded niosomes' surface was negatively charged in the absence of charge inducing agents (-16.6 ± 1.4 mV) and also with DCP (-26.9 ± 1.0 mV), while it was positively charged (+8.7 ± 1.2 mV) with DOTAP. High entrapment efficiency was observed in all the formulations. MH-loaded niosomes were found to effectively sustain the release of drug, particularly with positively charged niosomes. The bioavailability of MH-loaded niosomes was assessed by measuring the serum values of glucose and metformin in the different studied Wistar rats groups. The pharmacokinetic data of MH-loaded niosomal preparation showed a significant prolongation and increased intensity of hypoglycemic effect more than that observed for free MH solution. Area above the blood glucose levels-time curve (AAC), maximum hypoglycemic response and time of maximum response (T(max)) were significantly higher (p < 0.001) when MH was administered in niosomal form compared to free drug solution. It could be concluded that MH-loaded niosome is promising extended-release preparation with better hypoglycemic efficiency.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin-loaded niosomes have better efficacy than pure metformin in reducing blood glucose levels.
“Pharmacokinetic testing confirmed the better efficacy of metformin-loaded niosomes over pure metformin in reducing blood glucose levels.84”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor
Trinder, P. (1969) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456326900600108 · Cited by 4,629 · see citing works
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · see citing works
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · see citing works
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998 · see citing works
Ladbrooke, B. D., Williams, R. M., & Chapman, D. (1968) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(68)90132-6 · Cited by 890 · see citing works
Clinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 640 · see citing works
Niosome: A future of targeted drug delivery systems
Kuotsu, K., Karim, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., & Behera, M. (2010) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/0110-5558.76435 · Cited by 627 · see citing works
YOSHIOKA, T., Sternberg, B., & Florence, A. T. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90228-3 · Cited by 476 · see citing works
Natali, A., & Ferrannini, E. (2006) · Diabetologia · doi:10.1007/s00125-006-0141-7 · Cited by 377 · see citing works
Studies on a high encapsulation of colchicine by a niosome system
Hao, Y., Zhao, F., Li, N., Yang, Y., & Li, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00301-0 · Cited by 365 · see citing works
Guinedi, A. S., Mortada, N. D., Mansour, S., & Hathout, R. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.023 · Cited by 356 · see citing works
Applications of nanotechnology to biotechnology
West, J. L., & Halas, N. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00082-3 · Cited by 343 · see citing works
Effect of liposomes and niosomes on skin permeation of enoxacin
Fang, J., Hong, C.-T., Chiu, W., & Wang, Y.-Y. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00627-5 · Cited by 310 · see citing works
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin
Pardakhty, A., Varshosaz, J., & Rouholamini, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.002 · Cited by 292 · see citing works
International Textbook of Diabetes Mellitus
DeCherney, G. S. (1993) · JAMA · doi:10.1001/jama.1993.03510150107047 · Cited by 285 · see citing works
Junyaprasert, V. B., Teeranachaideekul, V., & Supaperm, T. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9121-1 · Cited by 231 · see citing works
Role of Nanotechnology in Pharmaceutical Product Development
Devalapally, H., Chakilam, A. R., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20875 · Cited by 231 · see citing works
Bernkop‐Schnürch, A., Guggi, D., & Pinter, Y. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.005 · Cited by 221 · see citing works
Niosomes as carriers for tretinoin. I. Preparation and properties
Manconi, M., Sinico, C., Valenti, D., Loy, G., & Fadda, A. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00971-1 · Cited by 208 · see citing works
Essa, E. A. (2010) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.76752 · Cited by 147 · see citing works
Metformin in the digestive tract
Vidon, N., Chaussade, S., Noël, M., Franchisseur, C., Huchet, B., & Bernier, J. J. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80022-6 · Cited by 117 · see citing works
Corti, G., Cirri, M., Maestrelli, F., Mennini, N., & Mura, P. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.004 · Cited by 114 · see citing works
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system
El-Gazayerly, O. N., & Hikal, A. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00186-5 · Cited by 113 · see citing works
Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles
Carafa, M., Santucci, E., Alhaique, F., Coviello, T., Murtas, E., Riccieri, F. M., Lucania, G., & Torrisi, M. R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00294-9 · Cited by 111 · see citing works
Drug encapsulation and release from multilamellar and unilamellar liposomes
Betageri, G. V., & Parsons, D. L. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90015-t · Cited by 100 · see citing works
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides
Huang, Y., Chen, J., Chen, X., Gao, J., & Liang, W. (2007) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3193-4 · Cited by 91 · see citing works
Preparation and Characterization of Nonionic Surfactant Vesicles
van Hal, D. A., Bouwstra, J. A., van Rensen, A., Jeremiasse, E., de Vringer, T., & Junginger, H. E. (1996) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.0114 · Cited by 90 · see citing works
Essa, E. A. (2010) · Asian Journal of Pharmaceutics · doi:10.22377/ajp.v4i4.289 · Cited by 77 · see citing works
Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas, S. P., Mysore, N., Jaitely, V., & Venkatesan, N. (1998) · PubMed · Cited by 76 · see citing works
PREPARATION AND EVALUATION OF NIOSOMES CONTAINING ACECLOFENAC
Srinivas, S. P., & Kumar, Y. (2010) · Cited by 58 · see citing works
Occult Metformin Toxicity in Three Patients with Profound Lactic Acidosis
Perrone, J., Phillips, C., & Gaieski, D. F. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.11.055 · Cited by 52 · see citing works
Lebacq, E., & Tirzmalis, A. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90311-x · Cited by 40 · see citing works
Investigation of PEG 6000/Tween 80/Span 80/H2O niosome microstructure
Liu, T., & Guo, R. H. (2007) · Colloid & Polymer Science · doi:10.1007/s00396-006-1627-z · Cited by 24 · see citing works
Murugan, P., & Pari, L. (2007) · Journal of Applied Biomedicine · doi:10.32725/jab.2007.005 · Cited by 24 · see citing works
Niosomal Delivery Of Tenoxicam
Popli, H., & Nair, M. S. (1996) · Indian Journal of Pharmaceutical Sciences · Cited by 8 · see citing works
Formulation and Evaluation of Timolol Maleate Loaded Niosomes as an Ocular Drug Delivery System
Solyman, A. A. H. (2004) · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi, S., Nayak, A. K., & Behera, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110708 · Cited by 726 · see citing works
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
Souto, E. B., Souto, S. B., Campos, J. R. S., Severino, P. B., Pashirova, T. N., Zakharova, L. Y., Silva, A. M., Durazzo, A., Lucarini, M., Izzo, A. A., et al. (2019) · Molecules · doi:10.3390/molecules24234209 · Cited by 245 · see citing works
Nanotechnology based approaches for anti-diabetic drugs delivery
Kesharwani, P., Gorain, B., Low, S. Y., Tan, S. A., Ling, E. C. S., Lim, Y. K., Chin, C. M., Lee, P. Y., Lee, C. M., Ooi, C. H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.018 · Cited by 200 · see citing works
Swamy, B. Y., & Yun, Y. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.03.019 · Cited by 164 · see citing works
Dadashzadeh, S., Haeri, A., Daeihamed, M., Arzani, G., & Kaboutaraki, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84703 · Cited by 126 · see citing works
Trends of nanotechnology in type 2 diabetes mellitus treatment
Simos, Y. V., Spyrou, K., Patila, M., Karouta, N., Stamatis, H., Gournis, D., Dounousi, E. C., & Peschos, D. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.05.001 · Cited by 112 · see citing works
Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride
Çetin, M., & Şahin, S. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1089957 · Cited by 111 · see citing works
Novel drug delivery system: an immense hope for diabetics
Rai, V. K., Mishra, N., Agrawal, A. K., Jain, S., & Yadav, N. P. (2014) · Drug Delivery · doi:10.3109/10717544.2014.991001 · Cited by 102 · see citing works
Uppal, S., Italiya, K. S., Chitkara, D., & Mittal, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.049 · Cited by 98 · see citing works
Lipid-Based Nanovesicular Drug Delivery Systems
Limongi, T., Susa, F., Marini, M., Allione, M., Torre, B., Pisano, R., & Fabrizio, E. M. D. (2021) · Nanomaterials · doi:10.3390/nano11123391 · Cited by 87 · see citing works
Shukla, S. K., Kulkarni, N. S., Chan, A., Parvathaneni, V., Farrales, P., Muth, A., & Gupta, V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110559 · Cited by 83 · see citing works
Samed, N., Sharma, V., & Sundaramurthy, A. (2017) · Applied Surface Science · doi:10.1016/j.apsusc.2017.11.055 · Cited by 82 · see citing works
Therapeutic medications against diabetes: What we have and what we expect
Hu, C., & Jia, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.008 · Cited by 80 · see citing works
Niosome Preparation Techniques and Structure—An Illustrated Review
Mawazi, S. M., Ge, Y., & Widodo, R. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010067 · Cited by 75 · see citing works
Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update
Mishra, V. K., Nayak, P., Sharma, M., Albutti, A., Alwashmi, A. S. S., Aljasir, M. A., Alsowayeh, N., & Tambuwala, M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101568 · Cited by 71 · see citing works
El-Nabarawi, M. A., Tag, R., Teaima, M. H. M., Abary, M. Y. S., El-Mofty, H. M., Khafagy, M. M., Lotfy, N. M., & Salah, M. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1579827 · Cited by 71 · see citing works
Maestrelli, F., Mura, P., González-Rodrı́guez, M. L., Cózar-Bernal, M. J., Rabasco, A. M., Mannelli, L. D. C., & Ghelardini, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.083 · Cited by 68 · see citing works
Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine
Khalifa, A.-Z. M., & Rasool, B. K. A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0780-7 · Cited by 65 · see citing works
Akbarzadeh, I., Keramati, M., Azadi, A., Afzali, E., Shahbazi, R., Chiani, M., Norouzian, D., & Bakhshandeh, H. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105019 · Cited by 64 · see citing works
Kulkarni, P., Rawtani, D., & Barot, T. D. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.01.004 · Cited by 63 · see citing works
Raafat, K. M., & El‐Zahaby, S. A. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00321-1 · Cited by 62 · see citing works
Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles.
Akbari, V., Abedi, D., Pardakhty, A., & Sadeghi‐Aliabadi, H. (2015) · Europe PMC (PubMed Central) · Cited by 62 · see citing works
Adetunji, C. O., Michael, O. S., Rathee, S., Singh, K. R., Ajayi, O. O., Adetunji, J. B., Ojha, A., Singh, J., & Singh, R. P. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100198 · Cited by 60 · see citing works
Sabry, S. A., Ramadan, H. E., Elghany, M. A., Okda, T. M., & Hasan, A. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102163 · Cited by 58 · see citing works
Self-citationNanomedicines for endothelial disorders
Chung, B. L., Toth, M. J., Kamaly, N., Sei, Y. J., Becraft, J. R., Mulder, W. J. M., Fayad, Z. A., Farokhzad, O. C., Kim, Y., & Langer, R. (2015) · Nano Today · doi:10.1016/j.nantod.2015.11.009 · Cited by 58 · see citing works
Mohsen, A. M., AbouSamra, M. M., & ElShebiney, S. A. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1310224 · Cited by 58 · see citing works
Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin
Imran, M. A., Shah, M. R., Ullah, F., Ullah, S., Elhissi, A. M. A., Nawaz, W., Ahmad, F., Sadiq, A., & Ali, I. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1214991 · Cited by 56 · see citing works
Fouad, S. A., Teaima, M. H. M., Gebril, M. I., Abd-Allah, F. I., El-Nabarawi, M. A., & Elhabal, S. F. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2181747 · Cited by 46 · see citing works
Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation
El-Ridy, M. S., Yehia, S. A., Elsayed, I., Younis, M. M., Abdel-Rahman, R. F., & El-Gamil, M. A. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1556291 · Cited by 45 · see citing works
Li, Y., Luo, J., Lin, M., Zhi, P., Guo, W.-W., Han, M. Y., You, J., & Gao, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00199 · Cited by 45 · see citing works
Lee, S., & Hassan, Y. A. (2017) · International Journal of Heat and Mass Transfer · doi:10.1016/j.ijheatmasstransfer.2017.09.047 · Cited by 43 · see citing works
Shukla, S. K., Nguyen, V., Goyal, M., & Gupta, V. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0045 · Cited by 41 · see citing works
Kenechukwu, F. C., Nnamani, D. O., Duhu, J. C., Nmesirionye, B. U., Momoh, M. A., Akpa, P. A., & Attama, A. A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09099 · Cited by 40 · see citing works
Saini, N., Sodhi, R. K., Bajaj, L., Pandey, R. S., Jain, U. K., Katare, O. P., & Madan, J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.016 · Cited by 39 · see citing works
AbouSamra, M. M., Basha, M., Awad, G. E. A., & Mansy, S. S. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.014 · Cited by 39 · see citing works
Recent developments in nanoparticles for the treatment of diabetes
Sharma, D. K., Pattnaik, G., & Behera, A. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2261077 · Cited by 37 · see citing works
Debele, T. A., & Park, Y. C. (2022) · Life · doi:10.3390/life12122078 · Cited by 34 · see citing works
Malbois, P., Salaün, E., Vandel, A., Godard, G., Cabot, G., Renou, B., Boukhalfa, A. M., & Grisch, F. (2019) · Combustion and Flame · doi:10.1016/j.combustflame.2019.03.041 · Cited by 32 · see citing works
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
Luo, X., Yan, C., & Feng, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.004 · Cited by 32 · see citing works
Liu, F., Jin, H., Wang, Y., Chen, C., Li, M., Mao, S., Wang, Q., & Li, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1333170 · Cited by 32 · see citing works
Application of Nanomaterials in the Diagnosis and Treatment of Genetic Disorders
Aljabali, A. A. A., Obeid, M. A., Amawi, H. A., Rezigue, M. M., Hamzat, Y., Satija, S., & Tambuwala, M. M. (2020) · Springer eBooks · doi:10.1007/978-981-15-4802-4_7 · Cited by 30 · see citing works
Arafa, K., Shamma, R. N., El-Gazayerly, O. N., & El-sherbiny, I. M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1438463 · Cited by 29 · see citing works
Ullah, S., Shah, M. R., Shoaib, M., Imran, M. A., Shah, S. W. A., Ali, I., & Ahmed, F. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1291667 · Cited by 27 · see citing works
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus
Mohsen, A. M. (2019) · Current Drug Targets · doi:10.2174/1389450120666190307101642 · Cited by 26 · see citing works
Salmani-Javan, E., Jafari-Gharabaghlou, D., Bonabi, E., & Zarghami, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193708 · Cited by 24 · see citing works
Characterization of insulin-loaded liposome using column-switching HPLC
Ohnishi, N., Tanaka, S., Tahara, K., & Takeuchi, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.056 · Cited by 24 · see citing works
Kashani-Asadi-Jafari, F., & Hadjizadeh, A. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220224103406 · Cited by 23 · see citing works
Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment
Basheer, H. A., Alhusban, M. A., Alkilani, A. Z., Alshishani, A., Elsalem, L., & Afarinkia, K. (2023) · Cancers · doi:10.3390/cancers15205004 · Cited by 23 · see citing works
Raj, J., & Uppuluri, K. B. (2015) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/585 · Cited by 23 · see citing works
Core–shell drug carriers: liposomes, polymersomes, and niosomes
Dan, N. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00002-6 · Cited by 21 · see citing works
Gorosábel, A., Pedrana, J., Bernad, L., Caballero, V. J., Muñoz, S. D., & Maceira, N. (2019) · Agriculture Ecosystems & Environment · doi:10.1016/j.agee.2019.04.002 · Cited by 21 · see citing works
Formulation and evaluation of Metformin Hydrochloride-loaded Curcumin–Lycopene Niosomes
Katrolia, A., Chauhan, S. B., & Shukla, V. K. (2019) · SN Applied Sciences · doi:10.1007/s42452-019-1768-6 · Cited by 20 · see citing works
Zidan, A., Saadany, A. A. E., Maghraby, G. M. E., Abdin, A. A., & Hedya, S. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116448 · Cited by 20 · see citing works
Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update
Kumar, A., Mazumder, R., Rani, A., Pandey, P., & Khurana, N. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998261903230921102620 · Cited by 20 · see citing works
Kulkarni, P., Rawtani, D., Rajpurohit, S., Vasvani, S., & Barot, T. D. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103627 · Cited by 19 · see citing works
A POD-based reduced-order model for uncertainty analyses in shallow water flows
Zokagoa, J.-M., & Soulaïmani, A. (2018) · International journal of computational fluid dynamics · doi:10.1080/10618562.2018.1513496 · Cited by 19 · see citing works
Verma, A., & Riaz, U. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.03.072 · Cited by 18 · see citing works
Exploring the use of niosomes in cosmetics for efficient dermal drug delivery
Abu‐Huwaij, R., Alkarawi, A., Salman, D., & Alkarawi, F. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2233613 · Cited by 17 · see citing works
Sahu, A. K., & Verma, A. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0229-0 · Cited by 17 · see citing works
Enhancement of the Anti-inflammatory Efficacy of Betamethasone Valerate via Niosomal Encapsulation
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac116.1464014660 · Cited by 17 · see citing works
Raychaudhuri, R., Pandey, A., Hegde, A. R., Fayaz, S. M. A., Chellappan, D. K., Dua, K., & Mutalik, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1819237 · Cited by 15 · see citing works
Ossai, E. C., Madueke, C. A., Amadi, E. B., Ogugofor, M. O., Momoh, A. M., Okpala, C. O. R., Anosike, C. A., & NJOKU, O. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062852 · Cited by 15 · see citing works
Bhardwaj, S., & Bhatia, S. (2020) · PubMed Central · doi:10.22037/ijpr.2020.112887.14003 · Cited by 14 · see citing works
Kattar, A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1953466 · Cited by 14 · see citing works
Dan, N. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00001-6 · Cited by 14 · see citing works
Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery
Zhang, J., Liu, X., Lin, J., Bao, X., Peng, J., Gong, Z., Luan, X., & Chen, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121979 · Cited by 13 · see citing works
Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M. A., Rahman, F. I., Mohamed, I. N., & Reza, M. S. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s432790 · Cited by 11 · see citing works
Arshad, N., Shaheen, F., Khan, I. N., Naeem, S., Riaz, M., Siddique, M. I., Ayesha, M., & Waqar, M. A. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2426611 · Cited by 11 · see citing works
Cheng, X., Xu, Y., Jia, Q., Guo, N., Wang, Z., & Wang, Y. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1809555 · Cited by 11 · see citing works
Key Aspects in Nanotechnology and Drug Delivery
Arias, J. L. (2014) · CRC Press eBooks · doi:10.1201/b17271-2 · Cited by 11 · see citing works
NIOSOMES VERSUS PRONIOSOMES AS PROMISING DRUG DELIVERY SYSTEMS IN TREATMENT OF DIABETES MELLITUS
Teaima, M. H. M., Gebril, M. I., Abd-Allah, F. I., & El-Nabarawi, M. A. (2022) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2022v14i5.44039 · Cited by 10 · see citing works
Sheta, N. M., El-Gazar, A. A., Ragab, G. M., Essa, M. A., Abdel-Haleem, K. M., & El-Dahmy, R. M. (2024) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.031 · Cited by 10 · see citing works
A de novo formulation of metformin using chitosan‐based nanomicelles for potential diabetes therapy
Abbasian, M., Bighlari, P., Mahmoodzadeh, F., Acar, M. H., & Jaymand, M. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48037 · Cited by 10 · see citing works
Younes, N. F., Latif, R., Badawi, A. A. E.-L., & Hegazy, K. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100357 · Cited by 9 · see citing works
Nanocarriers and Diabetes: New Vistas and the Way Ahead
Mishra, D. K., Gautam, R. K., Dixit, P. V., & Sharma, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666221227140728 · Cited by 9 · see citing works
Abdel-Aziz, R. T. A., Aly, U. F., & Mady, F. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102235 · Cited by 9 · see citing works
Organogel investigations as a floating oral system with depot property
Kadoori, Z. S., Mohamed, M. B. M., & Numan, N. A. M. (2022) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v20i4.783 · Cited by 8 · see citing works
Rezvanjou, S. N., Niavand, M. R., Shayesteh, O. H., Yeganeh, E. M., Moghadam, D. A., Derakhshandeh, K., & Mahjub, R. (2023) · Journal of Microencapsulation · doi:10.1080/02652048.2023.2170488 · Cited by 8 · see citing works
Silybin-based herbal nanocarriers: an advancement in anticancer therapy
Shete, M. B., Deshpande, A. S., & Shende, P. K. (2022) · Materials Technology · doi:10.1080/10667857.2022.2081286 · Cited by 8 · see citing works
Therapeutic applications of nanomedicine in metabolic diseases by targeting the endothelium
Hou, L., Zhang, M., Liu, L., Zhong, Q., Xie, M., & Zhao, G. (2022) · QJM · doi:10.1093/qjmed/hcac210 · Cited by 7 · see citing works
Nanomedicine’s transformative impact on anti-diabetic drug discovery: an appraisal
Saini, K., & Sharma, S. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05870-8 · Cited by 7 · see citing works
Al‐Najjar, A. H., Khalifa, M. K. A., Amin, O. M., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105745 · Cited by 7 · see citing works
Chauhan, N., Kumar, M., Kumar, K., Chopra, S., & Bhatia, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128313325240513113840 · Cited by 7 · see citing works
Stable self-assembled oral metformin-bridged nanocochleates against hepatocellular carcinoma
El-Melegy, M. G., El-Kamel, A. H., Mehanna, R. A., Gaballah, A. H., & Eltaher, H. M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01724-5 · Cited by 7 · see citing works
Fingolimod loaded niosomes attenuates sevoflurane induced cognitive impairments
Weng, H., Liu, X., Ren, Y., Li, Y., & Li, X. (2021) · Biomedical Microdevices · doi:10.1007/s10544-021-00603-x · Cited by 7 · see citing works
Nanotechnology: Antidiabetics, Antioxidant and Anti-inflammatory
Samrat, K., Murthy, T. P. K., Divyashri, G., Krishna, R. H., & Chandraprabha, M. N. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_8 · Cited by 6 · see citing works
RECENT ADVANCES IN TREATMENT APPROACHES FOR DIABETES MELLITUS AND RELATED COMPLICATIONS: A REVIEW
Dhyani, S., Butola, M., Sautha, V., & Jakhmola, V. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i2.53184 · Cited by 5 · see citing works
Potential Nanomaterials for the Treatment and Management of Diabetes Mellitus
Tiwari, S. S., & Wadher, S. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_11 · Cited by 5 · see citing works
Amin, N. A. B. M., Hussen, R. S. D., Lee, S. M., Sim, K. S., & Navanesan, S. (2019) · Main Group Metal Chemistry · doi:10.1515/mgmc-2019-0010 · Cited by 5 · see citing works
Pan, Q., Chen, C., & Yang, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2818-2 · Cited by 4 · see citing works
The Impact of Hyaluronic Acid Coating on the Cationic Niosomal Surface for Doxorubicin Delivery
Mazzotta, E., Romeo, M., Sacco, G., Benedittis, S. D., Qualtieri, A., Perrotta, I. D., & Muzzalupo, R. (2025) · Molecules · doi:10.3390/molecules30051148 · Cited by 3 · see citing works
Pinheiro, T. M., Almeida, T. C. D. A., Silva, J. D. O., Lopes, J. L., Cassali, G. D., Melo, M. M., Lempek, M. R., Ferreira, R. D. S., Townsend, D. M., Leite, E. A., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c08220 · Cited by 3 · see citing works
Chettupalli, A. K., Bukke, S. P. N., Rahaman, S. A., Bodige, M., Kanakaraju, V. K., Kavitha, M., Srinivasarao, D., Mohammed, A., Goruntla, N., & Yadesa, T. M. (2025) · BMC Biotechnology · doi:10.1186/s12896-025-01069-y · Cited by 3 · see citing works
Formulation and evaluation of sustained release tablets of propranolol hydrochloride
Purohit, D., Gupta, M. K., Meher, C. P., Shukla, A., & Kumar, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6287 · Cited by 3 · see citing works
Kenechukwu, F. C., Nnamani, D. O., Nmesirionye, B. U., Isaac, G. T., Momoh, M. A., & Attama, A. A. (2022) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09654-w · Cited by 3 · see citing works
An evaluation of the effects of ethosomes in the delivery of transdermal drugs
Gad, S., mousa, I., Hammady, T. M., & sayed, O. (2022) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2022.141371.1147 · Cited by 3 · see citing works
Javidan, A. N., Samadi, F. Y., Latifi, S., Jafari‐Nodoushan, M., & Mobedi, H. (2014) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(14)50082-2 · Cited by 3 · see citing works
Bhardwaj, A., Verma, S., Agnihotri, A., & Chitme, H. R. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2548844 · Cited by 2 · see citing works
Ghoraba, H., Ashrafi, F., Nadushan, R. M., & Abbaspour, H. (2026) · BMC Biotechnology · doi:10.1186/s12896-026-01132-2 · Cited by 2 · see citing works
- Authors
- Hasan, A. A., Madkor, H., & Wageh, S.
- Affiliations
- Zagazig University (EG)
- Al-Azhar University (EG)
- Corresponding author
- Hasan, Azza A.
- ORCID
- Madkor, Hafez
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-04
- Volume
- 20
- Issue
- 3-4
- Pages
- 120-126
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2163002418
- Cited by
- 122
- References
- 39
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 7 · 2023: 16 · 2022: 16 · 2021: 8 · 2020: 12 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 4 · 2015: 7 · 2014: 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- metformin hydrochloride, niosomes, controlled release, oral drug delivery, bioavailability, diabetes mellitus, lactic acidosis, DOTAP, dicetyl phosphate, encapsulation efficiency, hypoglycemic effect, pharmacokinetics, Span 40, cholesterol
- MeSH terms
- Animals, Blood Glucose, Chemistry, Pharmaceutical, Delayed-Action Preparations, Drug Evaluation, Preclinical, Liposomes, Male, Metformin, Random Allocation, Drug Delivery Systems, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review